Page last updated: 2024-09-03

1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and ave-8063

1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene has been researched along with ave-8063 in 1 studies

Compound Research Comparison

Studies
(1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene)
Trials
(1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene)
Recent Studies (post-2010)
(1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene)
Studies
(ave-8063)
Trials
(ave-8063)
Recent Studies (post-2010) (ave-8063)
11022009

Protein Interaction Comparison

ProteinTaxonomy1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (IC50)ave-8063 (IC50)
Tubulin beta-4A chainHomo sapiens (human)3.85
Tubulin beta chainHomo sapiens (human)3.85
Tubulin alpha-3C chainHomo sapiens (human)3.85
Tubulin alpha-1B chainHomo sapiens (human)3.85
Tubulin alpha-4A chainHomo sapiens (human)3.85
Tubulin beta-4B chainHomo sapiens (human)3.85
Tubulin beta-3 chainHomo sapiens (human)3.85
Tubulin beta-2A chainHomo sapiens (human)3.85
Tubulin beta-8 chainHomo sapiens (human)3.85
Tubulin beta-2B chainBos taurus (cattle)1.8333
Tubulin alpha-3E chainHomo sapiens (human)3.85
Tubulin alpha-1A chainHomo sapiens (human)3.85
Similar to alpha-tubulin isoform 1 Bos taurus (cattle)1.8333
Similar to alpha-tubulin isoform 1 Bos taurus (cattle)1.8333
Tubulin alpha-1C chainHomo sapiens (human)3.85
Tubulin beta-6 chainHomo sapiens (human)3.85
Tubulin beta-2B chainHomo sapiens (human)3.85
Tubulin beta-1 chainHomo sapiens (human)3.85

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CY; Chang, JY; Chen, CM; Kuo, CC; Liou, JP; Yang, MF1

Other Studies

1 other study(ies) available for 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and ave-8063

ArticleYear
2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Journal of medicinal chemistry, 2006, Oct-19, Volume: 49, Issue:21

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Stilbenes; Structure-Activity Relationship; Tubulin Modulators

2006